Response to Comments: MolDX: Molecular Biomarkers for Risk Stratification of Indeterminate Pulmonary Nodules Following Bronchoscopy

This document (A59843) is a response to comments on the MolDX Local Coverage Determination (DL39654) for molecular biomarkers used to risk-stratify indeterminate pulmonary nodules following bronchoscopy. The notice and effective dates are noted (notice begins 2024-08-08; effective 2024-09-22) but the provided text contains no clinical coverage criteria, indications, exclusions, documentation requirements, or frequency limits; review of the underlying LCD (DL39654) is required to extract those policy details.